Proposals - Gambro Annual General Meeting March 21, 2001

Proposals - Gambro Annual General Meeting March 21, 2001 Stockholm, Sweden, March 8, 2001 - Gambro AB (OM Stockholm Exchange: GAMBaST, GAMBbST), a leading international medical technology and healthcare company, today announced that shareholders representing more than 40 percent of the votes in the Company have given notice that they will make the following proposals in regard to items 11-14 on the Agenda at the Annual General Meeting: 11 Determination of the number of Board members and Deputy members Ten members and no deputies. 12 Determination of the fees to be paid to Board members Proposed fee to the Board in a fixed amount of SEK 3,775,000 for distribution among those members elected by the Annual General Meeting who are not employees of the Company. 13 Determination of the fees to be paid to auditors Proposed fee to auditors to be paid against invoice during the period extending to the next Annual General Meeting. 14 Election of the Board members and Deputy members Proposed candidates for reelection as members of the Board of Directors: Claes Dahlbäck, Gösta Gahrton, Peter H. Grassmann, Juha P. Kokko, Håkan Mogren, Sven Nyman and Björn Svedberg. Mikael Lilius has announced that he will decline reelection. Proposed candidates for election as new members are: Sandra Austin Crayton, Bill Gantz and Sören Mellstig. For further information please contact: Claes Dahlbäck, Chairman of Gambro AB, tel. +46-8-614 20 00 Bengt Modéer, Investor Relations, tel. +46-8-613 65 00, +46-733-66 65 33 Karin Avasalu, Corporate Communications, tel. +46-8-613 65 00, +46-70-513 65 99 Board members proposed for reelection Claes Dahlbäck, Chairman. BSc Econ. Born 1947. Elected 1998. Chairman of the Boards of Stora Enso, Vin & Sprit, EQT, IBX and imGO. Vice Chairman of Investor AB and Skandinaviska Enskilda Banken. Member of the Board of Findus. Gösta Gahrton, MD, PhD. Born 1932. Elected 1998. Professor at the Karolinska Institutet. Former head of the Department of Medicine at Huddinge Hospital and Chairman of the Karolinska Institutet's Nobel Prize Committee. President of the World Marrow Donor Association. Member of the Board of, among others, Marianne and Marcus Wallenberg's Foundation, and Principal of the King Gustaf V Jubilee Fund and the King Gustaf V 80 Year Fund. Peter H. Grassmann. MSc, PhD. Born 1939. Elected 1998. Former President and CEO of Carl Zeiss, Germany and member of the executive board of the Medical Systems Group of Siemens AG, Germany. Member of the Board of ASM-L Holding N.V., Netherlands. Member of the Advisory Boards of Allianz and Deutsche Bank, Germany, Massachusetts Institute of Technology, USA, Max- Planck-Gesellschaft, Munich, Germany. Member of several boards of start- ups and of the Private Equity Fund EQT in Germany. Juha P. Kokko, BSc, MD, PhD. Born 1937. Elected 1998. Asa G. Candler Professor of Medicine and Associate Dean for Clinical Research, Emory University, Atlanta, Georgia, USA. Former Chairman of Medicine at Emory University; Chief of Nephrology, University of Texas, Dallas, Texas, USA; Past President American Society of Nephrology, and Board Member of Discovery Therapeutics, Richmond, Virginia, USA, among other positions. Håkan Mogren, Vice Chairman. MSc, PhD, Dr h c. Born 1944. Elected 1996. Deputy Chairman of AstraZeneca PLC. Chairman of the Board of the Research Institute of Industrial Economics. Member of the Boards of Investor AB, Reckitt Benckiser PLC and the Federation of Swedish Industries. Sven Nyman. BSc Econ. Born 1959. Elected 1998. Executive Vice President of Investor AB. Vice Chairman of the Board of OM Gruppen and Member of the Board of Alecta. Björn Svedberg. MSc E E. Dr h c. Born 1937. Elected 1997. Member of the Boards of, among others, Investor AB, SAAB and Knut and Alice Wallenberg's Foundation. Chairman of Chalmers Institute of Technology and Chairman of the Royal Swedish Academy of Engineering Sciences. Proposed new Board members Sandra Austin Crayton. BSc, MPH, JD/LLD. Born 1948. President and CEO of PhyServ LLC. Member of the Boards of National City Corp., Ferro Corp. and Cancer Treatment Centres of America. Bill Gantz. MBA, BA. Born 1938. Former Chairman, President and CEO of PathoGenesis Corporation. Member of The Gillette Company, W.W. Grainger, Inc., Harris Bancorp, Inc., and Harris Trust and Savings Bank. Sören Mellstig. President and Chief Executive Officer. MBA. Born 1951. Employed 1994. Member of the Boards of Munters, MacGREGOR International and XCounter. ------------------------------------------------------------ This information was brought to you by BIT http://www.bit.se The following files are available for download: http://www.bit.se/bitonline/2001/03/08/20010308BIT00600/bit0002.doc http://www.bit.se/bitonline/2001/03/08/20010308BIT00600/bit0002.pdf